NasdaqGS:INCYBiotechs
Incyte Leadership Shift And Dermatology Data Shape Investment Case
Incyte (NasdaqGS:INCY) has appointed Pablo J. Cagnoni, M.D. as President and Global Head of R&D, alongside other executive changes aimed at tighter integration across its commercial units.
The company plans to spotlight multiple late-stage dermatology programs, including long term data for povorcitinib and real world outcomes for Opzelura, at the 2026 American Academy of Dermatology Annual Meeting.
These leadership moves and clinical updates come as Incyte prepares for upcoming product...